Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-046745
Filing Date
2025-03-28
Accepted
2025-03-28 16:00:21
Documents
89
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K isco-20241231.htm   iXBRL 10-K 2419332
2 EX-19.1 isco-ex19_1.htm EX-19.1 63938
3 EX-23.1 isco-ex23_1.htm EX-23.1 2836
4 EX-31.1 isco-ex31_1.htm EX-31.1 12924
5 EX-31.2 isco-ex31_2.htm EX-31.2 12790
6 EX-32.1 isco-ex32_1.htm EX-32.1 7495
7 EX-32.2 isco-ex32_2.htm EX-32.2 7665
8 GRAPHIC img265657751_0.jpg GRAPHIC 26380
9 GRAPHIC img265657751_1.jpg GRAPHIC 25275
  Complete submission text file 0000950170-25-046745.txt   11435020

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT isco-20241231.xsd EX-101.SCH 1391415
92 EXTRACTED XBRL INSTANCE DOCUMENT isco-20241231_htm.xml XML 2375783
Mailing Address 9745 BUSINESSPARK AVENUE SAN DIEGO CA 92131
Business Address 9745 BUSINESSPARK AVENUE SAN DIEGO CA 92131 760-940-6383
International Stem Cell CORP (Filer) CIK: 0001355790 (see all company filings)

EIN.: 204494098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51891 | Film No.: 25785646
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)